• Mashup Score: 0

    In this feature video, Dr Kristina Callis-Duffin, MD, MS shares what will be presented during her session, “Psoriasis & Psoriatic Arthritis – So Now What Do I Do?”, at the 2023 Fall Clinical Dermatology Conference.

    Tweet Tweets with this article
    • In this feature video, Dr Kristina Callis-Duffin shares what will be presented during her session, “Psoriasis & Psoriatic Arthritis - So Now What Do I Do?”, at the 2023 Fall Clinical Dermatology Conference. https://t.co/vqup5dOpjj #FallClinical #Derm #Dermatology #Dermatologist

  • Mashup Score: 0
    Home - 8 month(s) ago

    This year we’ re leaving our screens behind and meeting in person, because the 22nd Annual Psychopharmacology Update is more than just a conference; we’ re a community. For us, joining together again is an opportunity to enhance the learning experience through valuable face-to-face engagement and interaction. As always, our renowned faculty will bring you the latest advancements in psychiatry, from judicious psychopharmacology, evidence-based combinations, and management of treatment-resistant psychiatric

    Tweet Tweets with this article
    • 2 WEEKS UNTIL: #PsychPharm23 October 27-28 in Cincinnati, Ohio for the 22nd Annual Psychopharmacology Update. 🧪 Learn topics from judicious psychopharmacology, evidence-based combinations, addiction and psychedelics. Click here now: https://t.co/lDxyFDdh1N #PsychEd https://t.co/PV1NqR7T9D

  • Mashup Score: 0

    A recent study published in Lasers in Surgery and Medicine has unveiled a promising treatment option for individuals dealing with acne and its often-persistent aftermath of scars. Researchers have discovered that combining the 1927nm fractional thulium fiber laser (TFL) with 30% supramolecular salicylic acid (SSA) chemical peels significantly improves both acne and acne scars.

    Tweet Tweets with this article
    • A recent study has unveiled a promising treatment option for individuals dealing with acne and its often-persistent aftermath of scars. Read More: https://t.co/yUpzt2EHtK #Derm #Dermatology #Dermatologist #DermInsights #SkincareExperts #Dermatology101 #DermatologyExperts

  • Mashup Score: 0

    This cohort study describes and identifies patient characteristics associated with use of in-office narrowband UV-B (NBUVB) or systemic therapy following home NBUVB machine receipt.

    Tweet Tweets with this article
    • This cohort study describes and identifies patient characteristics associated with use of in-office narrowband UV-B (NBUVB) or systemic therapy following home NBUVB machine receipt. https://t.co/gWnNJJ3km0

  • Mashup Score: 0
    Home - 8 month(s) ago

    The treatment landscape for inflammatory bowel disease (IBD) is evolving rapidly, as novel pharmacologic agents continue to advance the treatment of Cro hn’s disease and ulcerative colitis. In this live symposium, 3 IBD experts will discuss and differentiate these new and emerging therapies, provide context for their use in clinical practice, and use patient cases to illustrate evolving concepts in risk stratification, treat-to-target approaches, and therapeutic monitoring. The symposium will be presented

    Tweet Tweets with this article
    • Experts use 🔍 evidence-based criteria to assess risk for disease progression in patients with IBD 📆 October 20, 2023 🏆 Earn 1.5 CME Credits 🔗 https://t.co/GovapTtSIg #IBD #Digestivehealth https://t.co/ligLS4fkDm

  • Mashup Score: 1

    Experts in dermatology discuss the use of oral and topical JAK inhibitors in clinical practice and their reflection of overarching treatment guidelines and indications.

    Tweet Tweets with this article
    • Dermatology experts address the use of oral and topical JAK inhibitors and their overarching treatment guidelines and indications in this informative Frontline Forum episode. Watch here: https://t.co/YNFbKYg5P0 https://t.co/3wTKX6U4TG